Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank86
Studio
Year-over-Year Change

Price-to-earnings ratio

Percentile
P86
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthCompressed
PeriodValueYoY Change
2025-1.03+36.7%
2024-1.62+80.0%
2023-8.11-38.8%
2022-5.85+74.6%
2021-22.99-115.8%
2020145.73+1663.9%
2019-9.32+4.3%
2018-9.74-221.7%
2017-3.03+33.6%
2016-4.55-